세계의 정맥주사(IV) 장비 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Intravenous (IV) Equipment Market is presumed to reach the market size of nearly USD 39.98 Billion by 2032 from USD 21.42 Billion in 2023 with a CAGR of 7.18% under the study period 2024-2032.

Intravenous (IV) equipment encompasses a range of devices and accessories used in healthcare settings to administer fluids, medications, and nutrients directly into patients' bloodstreams via intravenous therapy. These include IV catheters, infusion pumps, IV solution bags, tubing sets, and accessories such as connectors and needles. IV equipment is crucial in delivering precise doses of medications and fluids, ensuring efficient patient care during hospitalization, surgery, emergency treatment, and chronic disease management.

MARKET DYNAMICS

The Intravenous (IV) Equipment market is driven by the rising prevalence of chronic diseases requiring intravenous therapy, such as cancer, diabetes, and cardiovascular disorders. Technological innovations in infusion pumps, catheters, and tubing systems enhance safety, accuracy, and patient comfort, driving market expansion. Moreover, rising healthcare expenditure globally and expanding healthcare facilities in developing regions create opportunities for market penetration. Demand for home healthcare solutions and ambulatory care settings also boosts the adoption of portable and user-friendly IV equipment, facilitating patient mobility and improving quality of life.

Furthermore, regulatory initiatives promoting patient safety and healthcare quality standards encourage the adoption of advanced IV equipment with features such as wireless connectivity, integrated monitoring systems, and automated dose calculations. Strategic partnerships between healthcare providers and technology firms for product development and distribution strengthen market competitiveness and expand product portfolios. Additionally, the COVID-19 pandemic has underscored the importance of IV therapy in managing critically ill patients, driving immediate demand for infusion pumps, IV fluids, and related equipment in intensive care units and emergency departments. This surge has accelerated investments in IV equipment manufacturing and supply chain resilience, ensuring continuous availability during healthcare crises. However, pricing pressures, reimbursement uncertainties, infection control, and device safety concerns may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous (IV) Equipment. The growth and trends of Intravenous (IV) Equipment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous (IV) Equipment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• IV Catheters
• Administration Sets
• Infusion Pumps
• Securement Devices
• Drip Chambers
• Stopcocks and Check Valves
• Needless Connectors
• Others

By End-User

• Hospitals and clinics
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous (IV) Equipment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous (IV) Equipment market include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein Inc., Smiths Medical, Baxter, Ascor S.A., Moog Inc., AngioDynamics., ICU Medical Inc., Fresenius SE & Co. KGaA, Animas LLC, Arcomed Ag, International Win Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. INTRAVENOUS (IV) EQUIPMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By End-User
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. IV Catheters Historic and Forecast Sales By Regions
• 5.4. Administration Sets Historic and Forecast Sales By Regions
• 5.5. Infusion Pumps Historic and Forecast Sales By Regions
• 5.6. Securement Devices Historic and Forecast Sales By Regions
• 5.7. Drip Chambers Historic and Forecast Sales By Regions
• 5.8. Stopcocks and Check Valves Historic and Forecast Sales By Regions
• 5.9. Needless Connectors Historic and Forecast Sales By Regions
• 5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY END-USER

• 6.1. Overview By End-User
• 6.2. Historical and Forecast Data Analysis By End-User
• 6.3. Hospitals and clinics Historic and Forecast Sales By Regions
• 6.4. Diagnostic Centers Historic and Forecast Sales By Regions
• 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS (IV) EQUIPMENT COMPANIES

• 8.1. Intravenous (IV) Equipment Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF INTRAVENOUS (IV) EQUIPMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. B. Braun Melsungen AG
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. 3M
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Terumo Corporation
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Abbott
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Teleflex Incorporated
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. BD
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Henry Schein Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Smiths Medical
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Baxter
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Ascor S.A.
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Moog Inc.
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. AngioDynamics.
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. ICU Medical Inc.
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. Fresenius SE & Co. KGaA
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments
• 9.17. Animas LLC
  • 9.17.1 Company Overview
  • 9.17.2 Company Revenue
  • 9.17.3 Products
  • 9.17.4 Recent Developments
• 9.18. Arcomed Ag
  • 9.18.1 Company Overview
  • 9.18.2 Company Revenue
  • 9.18.3 Products
  • 9.18.4 Recent Developments
• 9.19. International Win Ltd
  • 9.19.1 Company Overview
  • 9.19.2 Company Revenue
  • 9.19.3 Products
  • 9.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies